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sing quantitative light microscopy and a modiﬁed
immunoelectron microscopic technique, we have
characterized the entry pathway of the cholera
toxin binding subunit (CTB) in primary embryonic ﬁbro-
blasts. CTB trafﬁcking to the Golgi complex was identical
in caveolin-1null (Cav1
 
 
 
/
 
 
 
) mouse embryonic ﬁbroblasts
(MEFs) and wild-type (WT) MEFs. CTB entry in the
Cav1
 
 
 
/
 
 
 
 MEFs was predominantly clathrin and dynamin
independent but relatively cholesterol dependent. Immuno-
electron microscopy was used to quantify budded and
U
 
surface-connected caveolae and to identify noncaveolar
endocytic vehicles. In WT MEFs, a small fraction of the total
Cav1-positive structures were shown to bud from the
plasma membrane (2% per minute), and budding in-
creased upon okadaic acid or lactosyl ceramide treatment.
However, the major carriers involved in initial entry of CTB
were identiﬁed as uncoated tubular or ring-shaped struc-
tures. These carriers contained GPI-anchored proteins and
ﬂuid phase markers and represented the major vehicles
mediating CTB uptake in both WT and caveolae-null cells.
 
Introduction
 
Endocytosis is a vital process required for many cellular pro-
cesses including nutrient uptake, membrane recycling, and signal
transduction. In comparison to the clathrin-mediated pathway,
alternative nonclathrin endocytic pathways are poorly understood.
However, evidence has accumulated over recent years for an
internalization route involving a lipid-based sorting mechanism
(Conner and Schmid, 2003; Parton and Richards, 2003). This
pathway has been proposed to involve either caveolae, flask-
shaped invaginations of the plasma membrane (PM) generated
by the expression of caveolin-1 (Cav1), or other structures of
undefined morphology but similar biochemical properties,
which have been termed lipid rafts.
The nonenveloped virus simian virus 40 (SV40) and the
bacterial protein cholera toxin (CT) have been extensively
studied as potential markers of a nonclathrin pathway (Pelkmans
et al., 2001; Parton and Richards, 2003). In fact, the pathways
taken by these two agents show many similarities. Both path-
ways use the ganglioside GM1 as a surface receptor (Tsai et al.,
2003); GM1 is enriched in caveolae (Parton, 1994) as well as in
apparently featureless lipid raft domains, and both SV40 and
CT are subsequently transported to the ER via a brefeldin A–
sensitive trafficking pathway (Richards et al., 2002). The most
compelling case for an entry pathway involving caveolae has
come from the studies of SV40. SV40 shows a striking enrich-
ment in caveolae as shown by immunoelectron microscopy
(Stang et al., 1997) and light microscopy using a Cav1GFP
fusion protein (Pelkmans et al., 2001). Interestingly, virus
binding induces caveolae budding, suggesting that caveolae at
steady state are relatively static surface features but budding
can be regulated. This finding is consistent with independent
FRAP studies of Cav1GFP (Thomsen et al., 2002) and earlier
studies suggesting regulated internalization of caveolae in
response to experimentally induced hyperphosphorylation using
the phosphatase inhibitor okadaic acid (OA; Parton et al., 1994).
Stimulation of caveolae budding by SV40 involves tyrosine
phosphorylation and recruitment of actin and dynamin (Pelkmans
et al., 2002). Similar characteristics of caveolae internalization
have been shown in studies of the endocytosis of albumin
(Minshall et al., 2000; Shajahan et al., 2004) and of specific
 
Correspondence to Robert G. Parton: R.Parton@imb.uq.edu.au
D.K. Sharma’s present address is Photometrics, Roper Scientific, Tucson, AZ
85706.
Abbreviations used in this paper: AA, ascorbic acid; Cav1, caveolin-1; CT,
cholera toxin; CTB, CT binding subunit; DN, dominant-negative; GEEC, GPI-AP–
enriched early endosomal compartment; GPI-AP, GPI-anchored protein; LacCer,
lactosyl ceramide; MEF, mouse embryonic fibroblast; OA, okadaic acid; PM,
plasma membrane; SV40, simian virus 40; Tf, transferrin; TfR, transferrin receptor;
WT, wild-type.
The online version of this article includes supplemental material. 
JCB • VOLUME 168 • NUMBER 3 • 2005 466
 
glycosphingolipids (Sharma et al., 2004). Intriguingly, the latter
studies suggest that internalization of caveolae in this system is
specifically stimulated by glycosphingolipids and by cholesterol
as judged by light microscopy and loss of surface caveolae
(Sharma et al., 2004). In addition, these studies have shown a role
for PKC and Src kinases in caveolae internalization and showed
activation of Src upon lipid addition (Sharma et al., 2004).
The involvement of caveolae in CT entry is less clear, and
evidence for and against a role for caveolae has been generated
in subsequent years. A series of elegant experiments showed
that CT association with lipid rafts, as judged by sensitivity to
cholesterol-disrupting agents and by generation of hybrid toxins
with different lipid specificities, is crucial for CT toxicity (Or-
landi and Fishman, 1998; Wolf et al., 1998). But are caveolae
essential for CT endocytosis? Studies of CT endocytosis in cells
that lack caveolae have yielded contradictory results. Although
most studies have concluded that caveolae are not required for
CT internalization occurring efficiently in cells lacking caveolae
(Orlandi and Fishman, 1998; Torgersen et al., 2001; Nichols,
2002), a recent study concluded that CT entry did not occur in
fibroblasts from mice lacking Cav1 and caveolae (Sotgia et al.,
2002). Additionally, it has been shown that a significant amount
of CT can enter various cell types through a clathrin-dependent
pathway (Shogomori and Futerman, 2001; Torgersen et al.,
2001; Nichols, 2002; Massol et al., 2004). The route by which
CT enters the cell may also depend on the level of GM1 expres-
sion at the PM; when GM1 levels are increased, the pathway for
CT uptake becomes more sensitive to cholesterol depletion, in-
dependently of Cav1 expression (Pang et al., 2004).
If caveolae are not essential for CT uptake, are there addi-
tional nonclathrin, noncaveolae lipid raft–dependent pathways
CT can use? Other lipid raft markers such as GPI-anchored pro-
teins (GPI-APs), originally thought to be endocytosed through a
caveolae-dependent process (Anderson et al., 1992), have now
been shown to enter the cell through a dynamin- and caveolae-
independent, cdc42-dependent pinocytic pathway (Sabharanjak
et al., 2002). Lipid raft–associated IL-2 has been shown to be
internalized in a pathway independent of clathrin and caveolae
but involving dynamin and RhoA (Lamaze et al., 2001).
Although evidence for a clathrin- and caveolae-indepen-
dent pathway is accumulating, the lack of ultrastructural identi-
fication of the carriers involved in the initial entry step has
hampered attempts to characterize the molecular machinery in-
volved in this pathway. We have now used light microscopy
and EM to examine CT entry in wild-type (WT) and Cav1-null
primary fibroblasts. We show that CT can be endocytosed via
three distinct pathways: clathrin coated pits, caveolae, and by a
major clathrin- and caveolin-independent pathway, which we
now characterize at the ultrastructural level for the first time.
 
Results
 
Development of an ultrastructural assay 
to quantitate caveolae budding
 
Our first aim was to examine the budding of individual caveo-
lae at the ultrastructural level. One limiting factor in studying
caveolae endocytosis has been the inability to distinguish indi-
vidual internal caveolae from surface-connected structures, as
particularly evident in certain cell types where surface-con-
nected caveolae structures can appear in the perinuclear area of
the cell (Parton et al., 2002). To discriminate between surface-
connected and internal structures, we made use of the observa-
tion that the HRP reaction on an extracellular surface can be
quenched by the use of the membrane-impermeable reducing
agent ascorbic acid (AA; Stoorvogel et al., 1996). This method
was optimized to discriminate between surface structures, even
those with extremely narrow connections to the extracellular
milieu, and internal budded structures (Fig. 1, protocol and val-
idation; and Fig. S1, available at http://www.jcb.org/cgi/con-
tent/full/jcb.200407078/DC1). In addition, the method was
modified to enable immunolabeling for caveolin to ensure that
only bona fide caveolin-positive structures were recognized as
budded caveolae. Labeled cell cultures were either processed
for preparation of ultrathin sections or were prepared for visual-
ization as whole-mount specimens using cells grown on grids.
To analyze caveolae budding, CT binding subunit (CTB)
conjugated to HRP (CTBHRP) was bound to the surface at
4
 
 
 
C, and the cells were warmed for time periods between 15 s
and 5 min. The DAB reaction was then performed on living
cells in the presence of AA at 4
 
 
 
C to allow reaction product
generation only in intracellular (budded) carriers. We focused
on very early stages of internalization to identify the first en-
docytic carriers. At 4
 
 
 
C, no DAB-labeled profiles were ob-
served, but after just 15 s of warming (adding warm media at
time 0, and then replacing with ice-cold medium after 15 s)
DAB-labeled profiles were evident (Fig. 1 and see Figs. 4 and 5).
After the DAB reaction and paraformaldehyde fixation the
cells were permeabilized and labeled for Cav1. The bulk of the
Cav1 labeling at the periphery of the cell was observed on
surface-connected CTBHRP-negative 60-nm-diam caveolae.
However, careful examination of many cells revealed a small
number of internal CTBHRP-positive budded caveolae after 15 s
(Fig. 1) as well as vesicular structures of the size and morphol-
ogy of clathrin coated vesicles and other tubular carriers (see
Figs. 4 and 5). No DAB-labeled caveolae were observed in
cells maintained at 4
 
 
 
C, showing that this small population of
caveolae had budded during the short period of warming.
Quantitation revealed that 
 
 
 
2% of the total pool of Cav1-posi-
tive caveolae were DAB positive, and thus detached from the
cell surface after warming cells for 1 min (Fig. 1 E). Thus, ca-
veolae can bud from the cell surface, but at steady state this
represents a relatively small pool of caveolae. We also ob-
served more complex structures labeled with internalized CTB-
HRP after 5 min of warming (Fig. 1 B). Some of these struc-
tures showed strong labeling of Cav1, and this often was
associated with areas of distinct caveolar morphology (Fig. 1,
A–C; and see Fig. 5, B and C). These structures are either ca-
veosomes, to which CTBHRP has been delivered, or detached
clusters of caveolae.
The use of this technique allowed us to identify budded
Cav1-labeled structures for the first time. Previous studies have
suggested that Cav1 can form endocytic carriers both by colocal-
ization with endocytic markers and by biochemical assays (In-
troduction). These studies were not able to distinguish between 
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individual caveolae that were surface connected, endocytic vesi-
cle carriers, or those that were part of endosomal structures. The
results presented here, identifying a small population of budded
caveolae, are consistent with previous studies in which caveolae
internalization appeared to be a relatively infrequent event but
could be stimulated. In particular, the phosphatase inhibitor OA
was shown to stimulate rapid internalization of caveolae as
judged by both EM (in the absence of methods to immunolabel
and identify budded caveolae) and using a biochemical method
(Parton et al., 1994), and in other studies using SV40 as a marker
in real-time light microscopic studies (Pelkmans et al., 2002).
Additionally, it has been shown that caveolae internalization can
be stimulated through the addition of glycosphingolipids such as
lactosyl ceramide (LacCer) to the PM (Sharma et al., 2004).
Therefore, we tested the effect of OA and LacCer in this system.
Treatment with 1 
 
 
 
M OA during the 5-min warming step caused
an increase in bona fide Cav1-positive CTBHRP-labeled struc-
tures from 
 
 
 
8% in control cells to 17% in OA-treated cells (Fig.
1, D–F). LacCer treatment caused a similar increase in internal
Cav1-labeled structures from 11 to 20% (Fig. 1, D–G). In both
cases, we observed an increase in both budded single caveolae
and larger structures with caveolar morphology. In the absence
of additional markers we cannot yet determine whether these
structures are caveosomes (Pelkmans et al., 2001) or a group of
caveolae that have budded as a unit from the PM (Parton et al.,
1994). Nevertheless, these findings show that in this cell type,
caveolae budding is infrequent but can be stimulated.
The results provide an explanation for numerous appar-
ently contradictory observations in different systems (Severs,
1988; Parton and Richards, 2003; van Deurs et al., 2003). Al-
though caveolae budding is infrequent, it can be stimulated by
SV40 (and presumably physiological ligands), and may be more
frequent in certain cell types, such as endothelial cells, than in
other cells where caveolae have been suggested to be static (such
as skeletal muscle [Kaisto et al., 1999] or adipocytes [Souto et
al., 2003]). The methods described here provide sufficient sensi-
tivity to identify and quantitate a small number of budded caveo-
lae that may play an important role in cellular function.
 
CTB trafficking to the Golgi is identical 
in WT mouse embryonic fibroblasts 
(MEFs) and Cav1
 
 
 
/
 
 
 
 MEFs
 
The aforementioned data show that in WT MEFs caveolae can
play a role in CTB internalization. However, the question of
whether or not caveolae are essential for CTB uptake remains
controversial (Introduction). To address this question, we in-
vestigated the entry of CTB into WT or Cav1
 
 
 
/
 
 
 
 MEFs by
quantitative light and electron microscopy. Cav1
 
 
 
/
 
 
 
 MEFs
contained no morphologically identifiable caveolae (unpub-
lished data). We first compared CTB uptake between the two
cell cultures by confocal microscopy using conditions and re-
agents that were apparently identical to those used in previous
studies (Sotgia et al., 2002). CTB binding to the surface was
comparable between the two cell lines as judged by quantifica-
Figure 1. Ultrastructural characterization of caveolae endocytosis. (A and B) WT MEFs with bound CTBHRP were warmed for 1 (A) or 5 min (B). The DAB
reaction was performed on ice in the presence ( AA) or absence ( AA) of AA, and then cells were processed for immunoelectron microscopy detection
of Cav1. A and B are representative of areas enriched in caveolae. (A) DAB reaction product is present in a small subset of budded (nonsurface-connected)
Cav1-positive caveolae (arrows) in cells treated with AA during the DAB reaction. A large number of caveolae were DAB negative and thus surface
connected (small arrowheads). Putative budded clathrin vesicles were also observed (large arrowhead). (B) After 5 min of CTBHRP uptake, Cav1 also
localized to DAB-positive internal structures ( AA), which had an irregular tubular morphology (defined operationally as clustered caveolae in E–G).
(C) WT MEFs with CTBHRP internalized for either 1 or 5 min were treated with DAB in the presence of AA, labeled for Cav1, and processed for whole-
mount visualization. Budded (DAB-positive) caveolae (arrow), surface-connected (DAB-negative) caveolae (arrowhead), and internal Cav1-positive larger
structures were observed. (D) WT MEFs were treated as in A but warmed for 5 min in the presence or absence of either OA or LacCer before the DAB
reaction in the presence of AA. (E–G) Quantitation of internal caveolae (single or clustered) as compared with the total number of caveolae present in the
same area with increasing time of incubation at 37 C (E) or after 5 min at 37 C in the presence/absence of OA (F) or LacCer (G). Error bars indicate
standard error. Bars: (A and B) 500 nm; (C and D) 200 nm. 
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tion of fluorescence intensity (unpublished data). CTB internal-
ized in both WT and Cav1
 
 
 
/
 
 
 
 MEFs occurred through quali-
tatively similar pathways with labeling of punctate peripheral
structures followed by accumulation in a GM130-positive peri-
nuclear compartment after 40 min (Fig. 2, A and B). The Golgi
localization of CTB in Cav1
 
 
 
/
 
 
 
 MEFs was confirmed by EM
(unpublished data). Quantification of CTB accumulation in the
Golgi complex (Fig. 2 C) showed that there were no significant
differences between WT and Cav1
 
 
 
/
 
 
 
 MEFs at any time
point between 5 and 40 min. Similar results were obtained
using a range of CTB concentrations from 0.05 to 1 
 
 
 
g/ml
(unpublished data). These results show that CTB entry does not
require caveolae. We investigated whether or not the two cell
lines differed in their sensitivity to CT using a single cell toxic-
ity assay (Massol et al., 2004). CT treatment (100 ng/ml for 2 h)
caused cell rounding indicative of cAMP production in 38 
 
 
 
6% of WT MEFs and 40 
 
 
 
 7% of Cav1
 
 
 
/
 
 
 
 MEFs. No differ-
ence in sensitivity to CT between the two cell lines was ob-
served at concentrations from 1 
 
 
 
g/ml to 1 ng/ml (unpublished
data). Pretreatment of cells for 1 h with brefeldin A (5 
 
 
 
g/ml)
greatly inhibited the alteration in the morphology of cells in the
presence of CT (unpublished data). This finding supports the
Figure 2. Internalization of CTB by WT and
Cav1 /  MEFs. (A–F) CTB-FITC was internal-
ized in WT MEFs (A and C) or Cav1 / 
MEFs (C) at 37 C for various times, and then
fixed and labeled for GM130 (A and C). The
accumulation of CTB within the Golgi complex
in both WT MEFs and Cav1 /  MEFs was
quantified (C); no significant differences were
seen. Bars indicate standard error. Cav1 / 
MEFs were microinjected with pIRES-Cav-1
using standard conditions (D) and short ex-
pression conditions (B and E). (B) Injected cells
(*) were marked by the production of cytosolic
GFP coded for by the same message as un-
tagged Cav1. CTB-Alexa Fluor 594 was inter-
nalized and CTB fluorescence intensity in the
GM130-positive region was quantified (D–F).
WT MEFs were microinjected with pIRES-Cav-1
using short expression conditions (F). Only
short expression of Cav1 reduced CTB traffick-
ing to the Golgi complex as compared with
nonexpressing cells in both WT and Cav1 / 
MEFs (D–F). (G) Cav1 /  MEFs were micro-
injected with vectors encoding for EPS15-DN-
GFP and TfR for short expression. CTB-FITC
was internalized simultaneously with Tf for
40 min. CTB-FITC was labeled with an anti-CT
antibody and a secondary antibody conju-
gated to Alexa Fluor 660. In cells that were
injected with EPS15-DN-GFP, Tf uptake was
inhibited, but CTB still accumulated in a peri-
nuclear compartment. (H) Cav1 /  MEFs
were microinjected with vectors encoding TfR
and either GFP or EPS15-DN-GFP (short ex-
pression), and then Tf uptake for 20 min was
performed. Internal Tf was quantified in in-
jected cells, and EPS15-DN-GFP inhibited Tf
uptake by 90%. (I) Cav1 /  MEFs were
microinjected with vectors encoding for
EPS15-DN-GFP (short expression), and CTB-
Alexa Fluor 594 was internalized for various
times. Quantification of CTB accumulation in
the GM130-positive Golgi complex revealed
that EPS15-DN-GFP reduced CTB trafficking
by only 40%. Bars indicate standard error;
*, P   0.01; **, P   0.001. Bars, 25  m. 
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light microscopic analysis of CTB trafficking to the Golgi
complex in the two cell lines.
Although these findings are consistent with several stud-
ies showing that caveolae are not required for CTB entry
(Orlandi and Fishman, 1998; Torgersen et al., 2001; Nichols,
2002), they are in apparent contradiction to the findings of Sot-
gia et al. (2002), who concluded that CTB uptake is dependent
on Cav1 and caveolae within MEF-derived cell lines. In our
hands, no conditions were found in which the WT and Cav1
 
 
 
/
 
 
 
MEFs differed in their handling of CTB. This was confirmed at
the EM level. However, one possibly significant difference in
the two studies is the use of immortalized cell lines of WT and
Cav1
 
 
 
/
 
 
 
 MEFs (Sotgia et al., 2002) rather than the primary
cultures as used here. During cell immortalization, a clonal
population of Cav1
 
 
 
/
 
 
 
 MEF cells with distinct properties
may have emerged. For example, Pang et al. (2004) reported
variation in GM1 levels within tissue culture cell lines, and the
subpopulation that contained low GM1 levels showed reduced
CTB uptake independent of Cav1 expression.
In several studies, Cav1 expression has been shown to in-
hibit rather than stimulate clathrin-independent endocytosis
(Minshall et al., 2000; Le et al., 2002; Sharma et al., 2004).
Therefore, we transiently expressed Cav1 in Cav1
 
 
 
/
 
 
 
 MEFs
by microinjection of the cDNA. After an overnight incubation,
CTB was added to the cells and accumulation in the Golgi
complex was quantified in Cav1-expressing versus nonex-
pressing neighboring cells after a 40-min incubation. Cav1
 
 
 
/
 
 
 
MEFs transiently expressing Cav1 showed a slight reduction in
levels of CTB in the Golgi, but this was not statistically signifi-
cant when compared with the population of noninjected cells
(Fig. 2 D). However, we noted a small number of highly ex-
pressing cells with a dramatic reduction in CTB accumula-
tion (unpublished data). To investigate this further, WT and
Cav1
 
 
 
/
 
 
 
 MEFs were microinjected with a higher amount of
the Cav1 cDNA and, after allowing expression for just 6 h, in-
cubated with CTB. Short expression of Cav1 (Fig. 2, B, E, and
F) but not short expression of GFP alone (not depicted) caused
a significant reduction in CTB trafficking to the Golgi complex
in both WT and Cav1
 
 
 
/
 
 
 
 MEFs. In contrast, transferrin (Tf)
uptake in cells expressing both Cav1 and the human transferrin
receptor (TfR) was not affected by Cav1 expression (unpub-
lished data), suggesting that inhibition is specific for a clathrin-
independent pathway.
These results are consistent with previous studies show-
ing that the transient expression of Cav1 reduced endocytosis
of several different endocytic markers but extend these studies
by showing that short or particularly high expression of Cav1
inhibits CTB uptake. This could reflect an increase in nonen-
docytic caveolae, which then sequester CTB at the PM into a
relatively static domain. This would diminish CTB labeling of
the Golgi complex by reducing the amounts of CTB entering the
cell. Alternatively, short expression of Cav1 might perturb the
cellular lipid balance and so disrupt caveolar and noncaveolar
endocytic pathways. This is consistent with findings that ex-
pression of Cav1 reduced albumin uptake in HeLa cells but this
inhibition was completely reversed and further stimulated by
addition of glycosphingolipids (Sharma et al., 2004).
 
CTB transport to the Golgi occurs via a 
clathrin- and caveolin-independent 
pathway that is sensitive to cholesterol 
depletion
 
The aforementioned experiments show that caveolae are not re-
quired for CTB entry. As CTB internalization has been re-
ported to occur through both clathrin-dependent and -indepen-
dent pathways (Torgersen et al., 2001; Nichols, 2002; Singh et
al., 2003), we examined the contribution of the clathrin coated
pit pathway to CTB entry using a well-characterized dominant-
negative (DN) form of EPS15 (Benmerah et al., 1999). Expres-
sion of EPS15-DN-GFP inhibited Tf uptake in TfR-expressing
MEFs by 90% (Fig. 2, G and H). Under these conditions, accu-
mulation of CTB in the Golgi region was only inhibited by
40% (Fig. 2, G and I). Thus, CTB uptake mainly occurred
through a noncaveolae nonclathrin pathway.
Next, we examined whether or not the CTB entry path-
way in the caveolae-null cells was sensitive to cholesterol de-
pletion. Cyclodextrin treatment was optimized to obtain condi-
tions in which clathrin coated pit–mediated endocytosis
was unaffected. As shown in Fig. S3 (available at http://
www.jcb.org/cgi/content/full/jcb.200407078/DC1), cyclodex-
trin treatment for 30 min after a 1-h serum-free period caused a
partial block in CTB uptake without affecting Tf uptake. Cho-
lesterol depletion can have diverse effects on cellular function,
including disruption of endosomal traffic (Minshall et al.,
2000; Le et al., 2002), secretion, (Wang et al., 2000), and even
perturbation of the actin network (Kwik et al., 2003). Neverthe-
less, our results show that cholesterol depletion partially inhib-
its CTB uptake without affecting Tf uptake.
We examined the role of dynamin in CTB entry. The DN
form of dynamin 1, DynK44A, has been shown to inhibit both
endogenous dynamin 1 and 2 function and to inhibit clathrin
and caveolar endocytosis (Damke et al., 1994; Oh et al., 1998).
Therefore, we expressed DynK44A in WT and Cav1
 
 
 
/
 
 
 
MEFs and examined CTB trafficking. As a control, Tf uptake
was quantified in the same cells transiently expressing the human
TfR. DynK44A reduced Tf uptake by 99–100% (Fig. S4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200407078/DC1).
When CTB uptake was examined in Cav1
 
 
 
/
 
 
 
 MEFs express-
ing Dyn1K44A (Fig. 3 A) or Dyn2K44A (not depicted), CTB
accumulated in extensive tubular structures (Fig. 3 A) and did
not label the Golgi complex after 40 min of internalization
(supplementary data). The extent of the tubular network varied
from cell to cell. Similar results were obtained with WT MEFs
(unpublished data). This network was not labeled by CTB
bound to cells at 4
 
 
 
C (Fig. S4), suggesting that the network was
intracellular. Therefore, a major fraction of CTB was endocy-
tosed in a dynamin-independent manner into a tubular network
induced by the dynamin DN mutant.
To gain further insights into the nonclathrin, noncaveolar
endocytic pathway, we examined the effect of an ARF6 mutant
on CTB entry. A clathrin-independent ARF6-dependent en-
docytic route has been described previously (Naslavsky et al.,
2004), although recent studies have suggested that CTB entry
may occur independently of ARF6 function (Massol et al.,
2004). Expression of ARF6 T27N, a DN mutant of ARF6, in 
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Cav1-null MEFs caused an identical phenotype to the expres-
sion of DynK44A (Fig. 3, B and C; and Fig. S5, available at
http://www.jcb.org/cgi/content/full/jcb.200407078/DC1). EM
of the microinjected cells showed internal CTBHRP-positive
tubules attached to multivesicular endosomes. This suggests
that CTB uptake occurs through a clathrin-independent, nonca-
veolar ARF6-independent pathway but suggests that ARF6
mutants disrupt subsequent trafficking to the Golgi complex.
 
Ultrastructural analysis of CT entry in 
WT and caveolae-null cells; identification 
of noncaveolar endocytic carriers
 
We have shown that CTB internalization does not require cave-
olae- or clathrin-mediated endocytosis. To characterize the
structures involved in CTB uptake, we examined the very first
endocytic carriers by EM using the modified DAB/AA method.
CTBHRP was bound to Cav1
 
 
 
/
 
 
 
 MEFs at 4
 
 
 
C and then the
cells were warmed for 15 s to allow visualization of the first in-
ternal carriers mediating CTBHRP uptake before fusion with
other compartments. The DAB reaction was first performed in
the presence of AA to visualize only internal structures, and the
cells were not permeabilized before processing. Morphologi-
cally distinct CTBHRP-labeled structures could be identified:
vesicular structures 
 
 
 
70-nm-diam (Fig. 4 A, arrowhead),
which were identical to structures labeled with TfHRP at early
times of warming (Fig. 4 C), and tubular structures with a tubu-
lar profile diameter between 50–80 nm. The latter were the ma-
jor structures labeled at this time and were often present in
groups close to the PM (Fig. 4 A). The tubular structures were
often observed as ring-shaped structures (Figs. 4 and 5). In
view of the short time of warming, we hypothesized that the tu-
bular/ring-like structures, which were the major structures la-
beled at this time, were formed through direct budding from the
PM. Interestingly, this hypothesis was supported by the obser-
vation that similar surface-connected tubular structures could
be observed when CTBHRP was bound to the surface of
Cav1
 
 
 
/
 
 
 
 MEFs and the DAB reaction was performed in the
absence of AA (Fig. 4 B). Further markers will be required to
confirm that such tubules are indeed the same structures
“trapped” at 4
 
 
 
C before budding. An alternative explanation for
the formation of the tubular structures could be that short-lived
carriers bud from the PM and fuse within 15 s to form tubular
endosomes. To examine whether clathrin coated pit–derived
vesicles are capable of forming, or fusing with, tubular endo-
somes, after 15 s in this experimental system, we internalized
TfHRP and visualized internal structures. Virtually all TfHRP-
Figure 3. Dynamin and ARF6 mutants inhibit CTB
transport to the Golgi complex. Cav1 /  MEFs were
microinjected with cDNA for DynK44A (A) or ARF6
T27N (B and C; short expression). CTB Alexa Fluor 594
was internalized for 40 min (A and B). DynK44A and
ARF6 T27N that contained NH2-terminal HA tags were
labeled with anti-HA (A and B). CTB colocalizes with
DynK44A (A) and ARF6 T27N (B) in an extensive tubular
network. This is highlighted in enlargements in bottom
panels of A. (C) Cav1 /  MEFs were microinjected with
ARF6 T27N and HRP, and CTBHRP was internalized for
40 min at 37 C. Cells were prepared for EM and CTBHRP
was revealed by DAB cytochemistry. CTBHRP reaction
product was evident within a network of 40-nm-diam
tubular structures in the injected cells, some of which
connect to multivesicular regions (arrowheads). Bars:
(A, top; and B) 25  m; (A, bottom) 5  m; (C, left) 1  M;
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labeled structures (98%; see Materials and methods for details)
were vesicular structures of  70-nm-diam rather than tubules
(Fig. 4 C). In contrast, 85% of internal CTBHRP-labeled struc-
tures showed the tubular/ring-like morphology. The finding
that 15% of the structures carrying CTBHRP are derived from
the clathrin coated pit pathway supports our functional data on
the CTB uptake pathway (Fig. 2). Overall, the data strongly
support the hypothesis that the tubular/ring-like structures bud
directly from the PM and comprise the first carriers in the non-
clathrin, noncaveolae pathway.
To understand the relative importance of each of the early
carriers in CTBHRP uptake, the total number of DAB struc-
tures within a given area in the periphery of cells was quantified
(Fig. 5, E and F). The percentage of CTBHRP-labeled clathrin
coated vesicles was the same in WT and Cav1 /  MEFs (Fig.
5 E). When CTBHRP was internalized for 15 s, 1 min, or 5
min, vesicular carriers only made up  20% of the total DAB-
positive structures observed (Fig. 5 E), with the remainder be-
ing nonvesicular tubular/ring-shaped carriers in both cell cul-
tures (Fig. 5, A and D). The tubular/ring-like structures were
dynamin negative (not depicted), EEA1 negative (not de-
picted), and in WT MEFs only a minor fraction (5%) were
Cav1 positive (Fig. 5, B, C, and F). We conclude that the ma-
jority of the early carriers of CTBHRP in both WT and Cav1 / 
MEFs were tubular/ring-like structures, as seen in both sec-
tioned (Fig. 5, A and D) and whole-mount specimens (Fig. 5 C
and Fig. S1). The whole-mount method revealed the true extent
of the tubules in the absence of sectioning and also revealed
that the estimate of vesicular carriers in sectioned material,
quantified in Fig. 5 E, is likely to be an overestimate due to sec-
tioned tubules appearing as vesicular profiles. However, in WT
MEFs, a significant fraction of the internal vesicles of  70 nm
are likely to be budded caveolae.
To characterize the tubular/ring-like structures further,
we examined whether or not these carriers were sensitive to
cholesterol depletion. Using conditions where Tf uptake was
unaffected (Fig. S3), WT MEFs were depleted of cholesterol
and CTBHRP was internalized for 1 min before the DAB reaction
was performed in the presence of AA. In cholesterol-depleted
cells, tubular structures only accounted for 35% of the total
internal structures compared with 89% in the control cells. This
is also an additional confirmation that the tubular carriers are
not simply endosomes of the coated pit pathway. This data im-
plies that the tubular carriers are a major component of CTB
uptake and are sensitive to cholesterol depletion. We propose
that the tubular/ring-like structures bud directly from the PM
and are the major carriers involved in the noncaveolae non-
clathrin uptake of CTB in both WT and Cav1 /  MEFs. In
addition, we speculate that the nonvesicular carriers may be a
universal nonclathrin-dependent entry pathway as early nonca-
veolar CTB-labeled carriers in cell lines, such as Vero cells,
NIH3T3, and A431, showed similar morphological charac-
teristics (unpublished data).
Tubular carriers are involved in GPI-AP 
endocytosis
The structures described here show similarities to the early car-
riers involved in cdc42-dependent endocytosis of GPI-APs and
fluid phase markers (Sabharanjak et al., 2002). Therefore, we
incubated WT MEFs with HRP as a fluid phase marker for 15 s.
The labeled structures were morphologically similar to the
tubular/ring-shaped structures labeled with CTBHRP at early
times (Fig. 6 A), consistent with a significant role for these
structures in fluid phase uptake. In addition, these results sug-
gest that CTB itself is not dramatically modifying the morphol-
ogy or formation of the early carriers.
To test directly if a proportion of GPI-APs are cointernal-
ized with CTB, fluorescently-tagged antibodies to GPI-AP, flu-
orescent-dextran (fluid phase marker), -Tf, and -CTB were
cointernalized for 2 min in WT MEFs using the conditions and
Figure 4. Ultrastructural characterization of early carriers in Cav1 / 
MEFs. Cav1 /  MEFs were incubated with CTBHRP (A and B) or TfHRP
(C) at 4 C. They were warmed for 15 s at 37 C and DAB treated in the
presence of AA (A and C) or were DAB treated in the absence of AA without
a warming step to reveal the surface distribution of CTBHRP (B). All samples
were fixed and processed for EM without permeabilization. (A) CTBHRP
reaction product is evident within vesicular profiles (arrowheads) and tubu-
lar/ring-shaped profiles (arrows) close to the plasma membrane (PM). Note
the groups of labeled structures as most clearly evident in the low magnifi-
cation overview (top). (B) CTBHRP reaction product is evident over the entire
cell surface but tubular/ring-shaped profiles of similar morphology to those
detached from the surface after warming are evident (arrows). Also note the
labeling of vesicular profiles connected to the cell surface (arrowheads).
(C) In contrast to the structures labeled by CTBHRP after 15 s, TfHRP labels
vesicular profiles (arrowheads) close to the PM. Bars, 200 nm.JCB • VOLUME 168 • NUMBER 3 • 2005 472
reagents of Sabharanjak et al. (2002). In WT MEFs, a pool of
endocytosed GPI-APs colocalized with dextran but not Tf (un-
published data), which is consistent with the existence of a
noncaveolae nonclathrin pathway for GPI-AP endocytosis and
the existence of GPI-AP–enriched early endosomal compart-
ments (GEECs) in these cells as described previously in CHO
cells (Sabharanjak et al., 2002). CTB was also observed in dex-
tran-positive but Tf-negative endosomes (Fig. 6, B and C).
When GPI-AP, Tf, and CTB were cointernalized,  70% of all
Tf-negative GPI-AP endosomes were labeled with CTB (Fig.
6, D–F). As two Tf ligands of different colors that are cointer-
nalized give a maximum colocalization index of 80% in this as-
say (Sabharanjak et al., 2002), CTB may mark all GPI-AP in-
ternalization through a noncaveolae nonclathrin pathway into
GEECs. This implies that the major carriers of the noncaveolae
nonclathrin pathway involved in GPI-AP internalization are the
tubular/ring-like carriers. In terms of CTB endocytosis,  50%
of total internalized CTB colocalizes with GPI-AP (unpub-
lished data), suggesting that half of the CTB endocytosis oc-
curs via a noncaveolae nonclathrin pathway. This is also con-
sistent with the inability of dynamin and EPS15 inhibitors to
completely prevent CTB internalization (Fig. 2, G–I; and Fig. 3
A). Therefore, CTB can be internalized by multiple routes and
is not a specific marker for a nonclathrin noncaveolae pathway.
Together, these results strongly suggest that the novel
caveolae- and clathrin-independent tubular/ring-like carriers
identified here are the same structures, GEECs, shown to be in-
volved in the cdc42-dependent uptake of GPI-APs and fluid
phase markers (Sabharanjak et al., 2002). Using the EM meth-
ods described here, we are now in a position to undertake a de-
tailed examination of the role of regulatory proteins such as
cdc42, which have been implicated in this pathway. Tubular
carriers can play a major role in protein transport in other bio-
logical membrane systems (Polishchuk et al., 2003) and may
Figure 5. Ultrastructural characterization of early noncaveolar carriers in Cav1 /  MEFs and WT MEFs. WT (A, B, and E) and Cav1 /  (D and E)
MEFs with bound CTBHRP were warmed for 15 s, 1 min, or 5 min at 37 C and DAB treated in the presence of AA. Samples were immunolabeled for
Cav1 (A–C) or dynamin (clathrin-pit panels) and processed for EM. In both WT (A) and Cav1 /  (D) MEFs, CTBHRP reaction product was observed after
15 s, 1 min, and 5 min in tubular structures, ring-like structures, clathrin coated vesicles, and smaller vesicular structures. (B) In WT MEFs, CTBHRP-positive
nonvesicular structures partly colocalized with Cav1. The percentage of nonvesicular structures labeled with Cav1 was quantitated (F). (C) WT MEFs were
grown on grids, and CTBHRP was internalized for 5 min. Cells were prepared for whole-mount visualization. CTBHRP labeled short tubular or ring-shaped
structures, some of which are Cav1 positive. (E) Internal CTBHRP-positive structures in WT and Cav1 /  MEFs were classified according to morphology
(see Materials and methods) and quantitated as a percentage of total labeled structures. Most CTBHRP-labeled internal structures in both WT and Cav1 / 
MEFs were nonvesicular. Note that visualized structures of  70 nm diam included caveolae. Bars, 200 nm.CAVEOLAE AND NONCAVEOLAE-MEDIATED ENDOCYTOSIS • KIRKHAM ET AL. 473
represent a high capacity system for membrane movement. The
ultrastructural characterization of the carriers described here
and the development of a method for immunolabeling these
structures should facilitate characterization of these carriers in
the same way that clathrin coated pit internalization is being
elucidated at the molecular level.
Discussion
In this work, we have shown for the first time that bona fide
Cav1-positive caveolae can bud from the PM to mediate CTB
uptake. Budding can be stimulated by phosphatase inhibitors
and by specific lipids. Immunoelectron microscopy quantifica-
tion of internal Cav1-positive CTBHRP-labeled structures led
us to the conclusion that caveolae internalization is a relatively
minor pathway in WT MEFs. Previous papers have shown an
apparent high level of colocalization of the internalized gly-
cosphingolipid LacCer, CTB, and Cav1 (Singh et al., 2003;
Sharma et al., 2004), but this occurred under conditions where
LacCer treatment had stimulated caveolae budding (Sharma et
al., 2004). We now demonstrate that in the absence of stimu-
lated caveolae budding CTB can be internalized via a noncave-
olar pathway, and hence CTB shows low colocalization with
Cav1 at the ultrastructural level.
In WT and Cav1 /  MEFs, we have shown that approx-
imately half of the CTB entering the cell is through a clathrin-
mediated pathway, but a significant proportion of CTB inter-
nalization occurs through a nonclathrin, noncaveolar but
cholesterol-sensitive pathway. The precise contribution of each
pathway is hard to evaluate using inhibitor studies alone, as
Figure 6. Analysis of uptake of CTB, fluid
phase markers, and GPI-APs. (A) WT MEFs
were incubated with 10 mg/ml HRP as a fluid
phase marker for 15 s, and then DAB treated
in the presence of AA before being processed
for EM. Tubular carriers similar to the early
carriers containing CTBHRP are labeled by
HRP. (B and C) CTB, dextran, and Tf were
cointernalized for 2 min in WT MEFs, and the
boxed areas are enlarged in panel C. (D and E)
CTB GPI-AP and Tf were cointernalized for 2
min in WT MEFs. CTB colocalization with Tf
was observed in  50% of CTB-positive struc-
tures. Arrows highlight endosomes containing
CTB and GPI-AP but not Tf, and the boxed
areas are enlarged in panel E. (F) GPI-AP
and CTB colocalization were quantified to
give a colocalization index. Gray bar, colo-
calization between all GPI-AP–positive struc-
tures and CTB; blue bar, CTB colocalization
with GPI-AP–positive Tf-negative structures. Er-
ror bars indicate standard error. Bars: (A) 200
nm; (B–E) 10  m.JCB • VOLUME 168 • NUMBER 3 • 2005 474
disruption of any one process may cause up-regulation of an al-
ternative pathway (Damke et al., 1995). However, in untreated
WT MEFs, a significant proportion of endocytosed CTB colo-
calizes with GPI-AP and not Tf after short periods of uptake.
Moreover, we have also identified and characterized at the ul-
trastructural level the first structures involved in a major clath-
rin- and caveolae-independent pathway. These structures are
tubular/ring-like with a diameter of 40–80 nm.
It is interesting to speculate that the clathrin-, dynamin-,
and caveolin-independent, cholesterol-dependent endocytic
pathway described here may, in fact, represent a primitive en-
docytic mechanism. In budding yeast, endocytosis of fluid
phase markers is an actin-based process involving furrowed in-
vaginations of the PM (Mulholland et al., 1999). Endocytosis is
affected by specific mutants defective in production of ergos-
terol, the main sterol of yeast, and can occur without clathrin or
dynamin function (Munn, 2001; Pichler and Riezman, 2004).
Internalization of both fluid phase markers and GPI-APs in pri-
mary cultured cells from Drosophila melanogaster is similarly
dynamin independent (Guha et al., 2003). Thus, a caveolae-
and clathrin-independent pathway may represent a primordial
endocytic route. Intriguingly, our studies show that caveolin
expression can influence this pathway. This finding raises the
possibility that proteins such as caveolin or even clathrin might
add an additional level of fine regulatory control of vesicle for-
mation and fission in combination with other proteins of the
endocytic machinery such as dynamin.
The involvement of caveolae in endocytosis has been a
long-standing question in the field. The upstream receptors that
can trigger caveolae budding, perhaps of only a small number
of caveolae in vivo, will be of considerable interest. We can
also now address whether or not spatially localized subsets of
caveolae are internalized in response to specific stimuli. In ad-
dition, the morphological characterization of noncaveolar carri-
ers presented here should facilitate more detailed studies of a
specialized endocytic pathway for which the molecular ma-
chinery and cellular functions are currently largely unknown.
Materials and methods
Antibodies and reagents
Expression plasmids were generated or obtained from the following
sources: pIRES2-EGFP/Cav1 (gift of C.J. Fielding, University of California,
San Francisco, San Francisco, CA), TfR (gift of V. Gerke, Center for Molec-
ular Biology of Inflammation (ZMBE), University of Muenster, Muenster,
Germany), pEGFP-EPS-15/E 95/295 (gift of A. Yap, University of Queens-
land, Queensland, Australia), pCB DYN-K44A-HA (gift by S.L. Schmid,
Scripps Research Institute, La Jolla, CA), and pXS/HA-ARF-6 T27N (gift of
J.L Donaldson, Laboratory of Cell Biology, National Heart, Lung, and
Blood Institute, National Institutes of Health, Bethesda, MD). Antibodies
were obtained from the following sources: rabbit anti-caveolin and mouse
anti-GM130 (BD Biosciences), rabbit anti-CT (Sigma-Aldrich), rabbit anti-
HA (provided by T. Nilsson, Gothenburg University, Gothenburg, Sweden),
and mouse anti-dynamin, Hudy1 (S.L. Schmid). Secondary antibodies con-
jugated to Alexa Fluor 488, 647, or 660 and CTB conjugated to Alexa
Fluor 594 and Tf -Alexa Fluor 546 (Molecular Probes) were used. All other
reagents were purchased from Sigma-Aldrich unless otherwise stated.
Cell culture and microinjection
MEFs were generated from 13.5-d-old embryos from either pregnant
Cav1 /  mice or litter-matched WT mice as described previously (Ra-
zani et al., 2001). MEF cells were cultured in DME supplemented with
10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 100  g/ml strep-
tomycin (Invitrogen). MEF cells were not immortalized, and thus cells were
only cultured to passage 6. Microinjection was performed as described
previously (Richards et al., 2002). Cells were injected in the nucleus with
50–100  g/ml of plasmid DNA and allowed to recover overnight in nor-
mal growth media at 37 C. For short expression of proteins, cells were in-
jected with 150–200  g/ml of plasmid DNA and allowed to recover for
5–6 h before subsequent manipulations.
Immunofluorescence and cell labeling
Cells were processed for immunofluorescence microscopy as described
previously (Richards et al., 2002). CTB uptake was performed essentially
as described previously (Sotgia et al., 2002). In brief, 0.05–1  g/ml CTB
was bound to the cells on ice for 30 min in CO2-independent medium
(GIBCO BRL) containing 2 mM L-glutamine and washed on ice in CO2-inde-
pendent medium before internalization at 37 C, 5% CO2 in prewarmed
normal growth media, for various times. Tf internalization was performed
by first incubating the cells for 1 h in DME and 2 mM L-glutamine, and then
placing the cells in prewarmed DME with 10  g/ml Tf, normal growth
media for 20 min at 37 C, unless otherwise stated. The cells were washed
on ice in CO2-independent medium/acetic acid, pH 4.0, for 4 min fol-
lowed by a 5-min wash in CO2-independent medium. Cholesterol depletion
of the cells was performed by treating the cells for 1 h in DME and L-glutamine
and then incubating in DME containing 10 mg/ml methyl- -cyclodextrin for
30 min at 37 C, 5% CO2. Any subsequent uptake experiments were
performed in DME containing 10% (vol/vol) Lipoprotein-depleted serum.
25  M LacCer and 1  M OA treatment were prepared and performed as
described previously (Parton et al., 1994; Sharma et al., 2004).
An assay based on cAMP-dependent cell morphology change was
used to assess CT-induced toxicity as described previously (Massol et al.,
2004). Cells were incubated with cholera holotoxin (Sigma-Aldrich) in
DME plus 0.5% BSA for 2 h before the samples were scored for a change
in cell morphology. Brefeldin A (5  g/ml) treatment was performed on
cells for 1 h in normal growth media before incubation with CT in the con-
tinued presence of brefeldin A. Experiments were repeated three times.
Microscopy and fluorescence quantification
All images were taken on a 1024 confocal system using Lasersharp 2000
4.0. software (Bio-Rad Laboratories), Plan APO 60  (Olympus), NA 1.4,
20 W Kr:Ar laser or on a radiance 2000 confocal system (Bio-Rad Labo-
ratories) using Lasersharp 2000 4.0. software, Plan APO 100  (Nikon),
NA 1.4, 50 W Ar laser (488 nm excitation), He:Ne (543 nm excitation)
Red Diode (638 nm excitation; Fig. 3, A and B). Fig. 3 B was imaged us-
ing 3  digital zoom. All images were acquired at RT and all fluoro-
chromes used are described in Antibodies and reagents. All images were
processed using Adobe Photoshop version 7.0 and figures compiled with
Adobe Illustrator version 10.0. Cells prepared for immunofluorescence mi-
croscopy were mounted in 0.4% (wt/vol) p-phenylenediame, 85% glyc-
erol, and 20 mM Tris, pH 9.
CTB and Tf uptake was quantified on samples prepared simulta-
neously using identical conditions. Images used for quantification were
taken through the center of the cell as judged by maximizing Golgi labeling
(GM130) or Tf. All images were taken with identical acquisition parameters
per experiment, and then individual cells were cut out using Adobe Photo-
shop version 7.0. To quantify CTB accumulation in the Golgi and Tf uptake,
a mask-overlay method was used (see Online supplemental material).
Ultrastructural immunogold analysis of CTBHRP, TfHRP, and HRP uptake
MEF cells, cultured on 3-cm dishes, were washed in CO2-independent me-
dium, incubated in CO2-independent medium containing 10  g/ml CTB-
HRP at 4 C for 20 min, and then CTBHRP was internalized at 37 C in nor-
mal growth media. To stop internalization, the cells were placed on ice in
pre-chilled CO2-independent medium. Next, the cells were incubated for
20 min at 4 C in freshly prepared DAB buffer (1 mg/ml DAB and 0.012%
H2O2) with or without 50 mM AA in PBS and fixed with 2.5% glutaralde-
hyde for 1 h. MEFs were incubated with DME plus L-glutamine for 1 h at
37 C before being incubated with 30  g/ml TfHRP at 4 C for 20 min in
CO2-independent medium. This was followed by 15 s uptake in normal
growth media. The cells were processed for EM as described for CTHRP.
Fluid phase marker HRP (10 mg/ml) was continuously internalized in nor-
mal growth media for 15 s, cells were washed in PBS and incubated in
DAB buffer in the presence of AA for 5 min at RT before fixation with
2.5% glutaraldehyde for 1 h. Cells were embedded in Epon and cut par-
allel to the culture substratum.
For immunolabeling, cells were fixed in 4% PFA at RT for 1 h. They
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blocking solution (2% BSA in PBS, 10 min), and 0.1% Triton X-100 in PBS
(10 min). The cells were incubated with the blocking solution containing the
primary antibodies for 2 h, washed in PBS, then incubated anti–mouse or
rabbit IgG gold (5 or 10 nm) in blocking solution for 2 h. Cells were washed
in PBS and fixed in 2.5% glutaraldehyde for 1 h to permanently immobilize
the colloidal gold labeling. The cells were embedded in Epon and cut paral-
lel to the culture substratum. Additional “on-grid” staining of sectioned mate-
rial with uranyl acetate and lead citrate was performed when required.
Preparation of whole-mount specimens
Whole-mount cells were prepared by a modification of the protocol de-
scribed previously (Stoorvogel et al., 1996). MEFs were grown for 24–30 h
on golden grids (ProSciTech) carrying a carbon-coated Formvar film. After
internalization of CTBHRP, DAB reactions were performed in the presence
of AA. Cells were permeabilized with 0.1% Triton X-100 for 30 min before
fixation with 1% PFA for 1 h at 4 C and immunolabeled as described in the
previous paragraph. After final fixation with 2.5% glutaraldehyde, the cells
were extensively washed with H2O and the grids were immersed in methyl-
cellulose for 5 min, allowed to dry, and viewed without further processing.
Quantification of EM
To determine the percentage of internalized CTBHRP-positive endosomal
and vesicular structures, all DAB-positive structures were counted in a
given peripheral region of a cell in thin sections. Labeled structures were
classified as follows (Figs. 1, 4, and 5): nonvesicular structures, DAB-posi-
tive tubular and ring-like structures; vesicular structures, DAB-positive
round profiles of either 50–70 nm or  70 nm diameter. Caveolae were
defined by their characteristic size (50–70 nm diameter), shape, and
Cav1 labeling. To determine the percentage of total caveolae that were in-
tracellular, extracellular HRP reactions were inhibited by AA, and DAB-
positive and -negative caveolae were counted. In both cases, random
fields were photographed at a primary magnification of 30 K. Approxi-
mately 40–50 micrographs were examined for each condition.
To quantitate the effect of cholesterol depletion on CTBHRP internal-
ization and to quantitatively compare the carriers involved in uptake of Tf
and CTBHRP at early times, DAB-positive structures were classified as ve-
sicular ( 70 nm structures of vesicular appearance) or tubular (Figs. 4
and 5) in fields selected at random. Approximately 100–400 labeled
structures were examined, and similar results were obtained in two inde-
pendent experiments.
GPI-AP internalization and quantification
GPI-AP internalization experiments were performed as described previ-
ously (Sabharanjak et al., 2002) using WT MEFs. In brief, mCFP-GPI was
transiently expressed by transfection using Fugene (Roche) or microinjec-
tion of plasmid DNA. FAB fragment of anti-GFP-antibody coupled to 4
 g/ml CY3, 1  g/ml Alexa Fluor 488 CTB, 40  g/ml Alexa Fluor 647
Tf, or 1 mg/ml TMR dextran were cointernalized in various combinations
for 2 min. After endocytosis, cells were treated with AA buffer, PI-PLC, and
isotonic Glycine-HCl buffer, pH 1.5, to remove surface bound Tf, CFP-GPI,
and CTB, respectively. Cells were fixed and processed for high resolution
wide-field microscopy. All imaging and quantification methods used to de-
termine endocytic marker overlap were identical to those previously de-
scribed (Sabharanjak et al., 2002).
Online supplemental material
Fig. S1 shows the development and validation of the technique for ultra-
structural analysis of the early endocytic carriers in MEFs. Fig. S2 shows
de novo formation of caveolae upon expression of Cav1 in Cav1 / 
MEFs. Fig. S3 demonstrates that CTB uptake in Cav1 /  MEFs is partly
sensitive to cholesterol depletion. Figs. S4 and S5 show that mutants of
both dynamin and ARF6 inhibit CTB transport to the Golgi complex but
not internalization. Supplemental Materials and methods contain addi-
tional information regarding the quantification of CTB accumulation within
a GM130-positive region and the quantification of Tf uptake. Online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200407078/DC1.
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